Risk Factors for Gastrointestinal Colonization by ESBL-Producing Klebsiella pneumoniae and Escherichia coli in Anaesthesiology and Reanimation Intensive Care Unit

被引:0
|
作者
Mizrakci, Serpil Oguz [1 ]
Arda, Bilgin [2 ]
Erdem, Huseyin Aytac [2 ]
Uyar, Mehmet [3 ]
Tunger, Alper [4 ]
Sipahi, Oguz Resat [2 ]
Ulusoy, Sercan [2 ]
机构
[1] Medline Antalya Private Hosp, Infect Dis & Clin Microbiol Clin, Antalya, Turkey
[2] Ege Univ, Tip Fak, Enfeksiyon Hastaliklari & Klin Mikrobiyol Anabili, TR-35100 Izmir, Turkey
[3] Ege Univ, Fac Med, Dept Anaesthesiol & Reanimat, TR-35100 Izmir, Turkey
[4] Ege Univ, Fac Med, Dept Med Microbiol, TR-35100 Izmir, Turkey
来源
MIKROBIYOLOJI BULTENI | 2013年 / 47卷 / 02期
关键词
Extended-spectrum beta-lactamase; Klebsiella pneumoniae; Escherichia coli; intensive care unit; gastrointestinal colonization; nosocomial infection; INFECTION; ACQUISITION; RESISTANCE; OUTBREAK;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study it was aimed to investigate the risk factors for gastrointestinal colonization by extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae and Escherichia coli in intensive care unit (ICU) of anaesthesiology and reanimation, Ege University Faculty of Medicine, Izmir, Turkey. This study was performed prospectively on adult patients hospitalized in ICU of anaesthesiology and reanimation and rectal swab cultures were performed in all patients in the first 48 hours of hospitalization and every one week until discharge or death. Samples were transported to the laboratory in Stuart transport medium and were cultured on two EMB agar plates (one including 4 mg/L ceftazidime) and incubated for 48 hours. E.coli and K.pneumoniae isolates were identified by conventional methods. Antibiotic susceptibility tests were performed by disc diffusion method on Mueller Hinton agar and interpreted according to CLSI guidelines. ESBL was confirmed by double disc synergy test. A total of 140 patients (49 female 91 male; age range: 18-83 years, mean age: 56.3 years) were evaluated, and 41(29.3%) of the patients were found to be colonized with ESBL positive E.coli (n=39) or K.pneumoniae (n=2). The mean time for colonization was 11.15 +/- 10.91 (range between 2-39) days. Age and gender of the patients and antibiotic consumption before or during the stay in ICU of anaesthesiology and reanimation were not found to be associated with colonization (p>0.05). However length of ICU of anaesthesiology and reanimation stay in colonized patients was longer than non-colonized patients (27.59 +/- 22.52 vs. 17.78 +/- 11.74 days; p<0.05). Infectious episodes developed in 22% (9/41) of the colonized cases and three of the nine strains were isolated from the blood cultures, five from the urine cultures and one from both blood and bronchoalveolar lavage cultures. ESBL-positive E.coli or K.pneumoniae colonization was found as an independent risk factor for the development of infection (9/41 vs. 4/99 cases; p=0.002). Forward logistic regression analysis revealed that diabetes mellitus, immunosuppresive drug use and length of intubation were associated with ESBL-positive E.coli or K.pneumoniae colonization (p<0.05). The results of this study indicated that the risk of development of infection was significantly high in intensive care patients colonized by ESBL positive E.coli and K.pneumoniae and the identification of the related risk factors was critically important for the establishment of effective control measures.
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [31] Carriage of ESBL-producing Klebsiella pneumoniae and Escherichia coli among children in rural Ghana: a cross-sectional study
    Charity Wiafe Akenten
    Neyaz Ahmed Khan
    Joyce Mbwana
    Ralf Krumkamp
    Dennis Fosu
    Ellis Kobina Paintsil
    Kennedy Gyau Boahen
    James Osei-Mensa
    Oumou Maiga-Ascofare
    Jürgen May
    Kwasi Obiri-Danso
    Richard Odame Phillips
    Linda Aurelia Ofori
    Denise Dekker
    Antimicrobial Resistance & Infection Control, 12
  • [32] Genomic Insights into Colistin and Tigecycline Resistance in ESBL-Producing Escherichia coli and Klebsiella pneumoniae Harboring blaKPC Genes in Ecuador
    Ortega-Paredes, David
    Del Canto, Felipe
    Rios, Rafael
    Diaz, Lorena
    Reyes, Jinnethe
    Arias, Cesar A.
    Zurita, Jeannete
    ANTIBIOTICS-BASEL, 2025, 14 (02):
  • [33] Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit
    Pena, C
    Pujol, M
    Ricart, A
    Ardanuy, C
    Ayats, J
    Linares, J
    Garrigosa, F
    Ariza, J
    Gudiol, F
    JOURNAL OF HOSPITAL INFECTION, 1997, 35 (01) : 9 - 16
  • [34] Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study
    Hristea, Adriana
    Olaru, Ioana D.
    Adams-Sapper, Sheila
    Riley, Lee W.
    INFECTIOUS DISEASES, 2015, 47 (01) : 46 - 51
  • [35] Tracking over time the developing gut microbiota in newborns admitted to a neonatal intensive care unit during an outbreak caused by ESBL-producing Klebsiella pneumoniae
    Panelli, Simona
    Corbella, Marta
    Gazzola, Alessandra
    Piralla, Antonio
    Girello, Alessia
    Rampelli, Simone
    Candela, Marco
    Cambieri, Patrizia
    NEW MICROBIOLOGICA, 2020, 43 (04): : 186 - 190
  • [36] RISK FACTORS FOR ISOLATION OF THIRD GENERATION CEPHALOSPORIN RESISTANT ESCHERICHIA COLI OR KLEBSIELLA PNEUMONIAE IN INTENSIVE CARE
    Hill, C.
    INTENSIVE CARE MEDICINE, 2009, 35 : 198 - 198
  • [37] Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study
    Joshua T Freeman
    Joseph Rubin
    Gary N McAuliffe
    Gisele Peirano
    Sally A Roberts
    Dragana Drinković
    Johann DD Pitout
    Antimicrobial Resistance and Infection Control, 3
  • [38] Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study
    Freeman, Joshua T.
    Rubin, Joseph
    McAuliffe, Gary N.
    Peirano, Gisele
    Roberts, Sally A.
    Drinkovic, Dragana
    Pitout, Johann D. D.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2014, 3
  • [39] Risk of Drug Resistance and Repeated Infection with Klebsiella pneumoniae and Escherichia coli in Intensive Care Unit Cancer Patients
    Refay, Samah M.
    Ahmed, Eman H.
    Abd ELzaher, Ahmed R.
    Morsy, Ahmed M.
    Yasser, Manal M.
    Mahmoud, Ayman M.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2022, 25 (02) : 324 - 334
  • [40] Clinical and molecular epidemiology of ESBL producing Klebsiella pneumoniae and Escherichia coli in a tertiary hospital
    Harada, Y.
    Yanagihara, K.
    Kaku, N.
    Migiyama, Y.
    Nagaoka, K.
    Yamada, K.
    Morinaga, Y.
    Hasegawa, H.
    Izumikawa, K.
    Kakeya, H.
    Kohno, S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S90 - S90